Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | CNR2 | P34972 | 1/20 | 0.34 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.34 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.34 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.34 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.34 |
| ▸ | PTGES | O14684 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21046036 | 0.91 | HTT (0.47) | HTTSMN1; SMN2MEN1ALDH1A1KMT2A | |
| SCHEMBL21046037 | 0.85 | HTT (0.48) | HTTSMN1; SMN2MEN1ALDH1A1KMT2A | |
| SCHEMBL30580521 | 0.78 | HTT (0.52) | HTTSMN1; SMN2MEN1ALDH1A1KMT2A | |
| SCHEMBL19899411 | 0.75 | HTT (0.59) | HTTSMN1; SMN2MEN1ALDH1A1KMT2A | |
| SCHEMBL30580528 | 0.74 | HTT (0.54) | HTTSMN1; SMN2MEN1ALDH1A1KMT2A | |
| SCHEMBL30580525 | 0.73 | MEN1 (0.59) | HTTSMN1; SMN2MEN1ALDH1A1KMT2A | |
| SCHEMBL30580526 | 0.73 | MEN1 (0.59) | HTTSMN1; SMN2MEN1ALDH1A1KMT2A | |
| SCHEMBL21046032 | 0.72 | HTT (0.40) | HTTSMN1; SMN2MEN1ALDH1A1KMT2A | |
| SCHEMBL29243825 | 0.72 | MEN1 (0.56) | HTTSMN1; SMN2MEN1ALDH1A1KMT2A | |
| SCHEMBL30580520 | 0.72 | MEN1 (0.56) | HTTSMN1; SMN2MEN1ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12024490-B2 | Polymeric metal chelating compositions and methods of preparing same for controlling growth and activities of living cells and organisms for therapeutic use in treating diseases in animals, fish or humans | CHELATION PARTNERS INCORPORATED (CA) | 2024-07-02 | — | — | US | disclosed |
| US-20220002250-A1 | POLYMERIC METAL CHELATING COMPOSITIONS AND METHODS OF PREPARING SAME FOR CONTROLLING GROWTH AND ACTIVITIES OF LIVING CELLS AND ORGANISMS FOR THERAPEUTIC USE IN TREATING DISEASES IN ANIMALS, FISH OR HUMANS | JUBILANT CHEMSYS LTD. (IN) | 2022-01-06 | — | — | US | disclosed |
| US-11059785-B2 | Polymeric metal chelating compositions and methods of preparing same for controlling growth and activities of living cells and organisms | CHELATION PARTNERS INCORPORATED (CA) | 2021-07-13 | — | — | US | disclosed |
| US-20190169126-A1 | POLYMERIC METAL CHELATING COMPOSITIONS AND METHODS OF PREPARING SAME FOR CONTROLLING GROWTH AND ACTIVITIES OF LIVING CELLS AND ORGANISMS | CHELATION PARTNERS INCORPORATED (CA) | 2019-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220002250-A1 | POLYMERIC METAL CHELATING COMPOSITIONS AND METHODS OF PREPARING SAME FOR CONTROLLING GROWTH AND ACTIVITIES OF LIVING CELLS AND ORGANISMS FOR THERAPEUTIC USE IN TREATING DISEASES IN ANIMALS, FISH OR HUMANS | TFRC, HMBS, PICALM | HTT 1484/4885SMN1; SMN2 812/4885MEN1 2264/4885 |
| US-12024490-B2 | Polymeric metal chelating compositions and methods of preparing same for controlling growth and activities of living cells and organisms for therapeutic use in treating diseases in animals, fish or humans | TFRC, HMBS, PICALM | HTT 1484/4885SMN1; SMN2 812/4885MEN1 2264/4885 |
| US-11059785-B2 | Polymeric metal chelating compositions and methods of preparing same for controlling growth and activities of living cells and organisms | PICALM, HMBS, TFRC | HTT 3362/4885SMN1; SMN2 2683/4885MEN1 1739/4885 |
| US-20190169126-A1 | POLYMERIC METAL CHELATING COMPOSITIONS AND METHODS OF PREPARING SAME FOR CONTROLLING GROWTH AND ACTIVITIES OF LIVING CELLS AND ORGANISMS | PICALM, HMBS, TFRC | HTT 3362/4885SMN1; SMN2 2683/4885MEN1 1739/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.